Log in to download the data 
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 29/01/2026 | Pfizer Inc |
U.S.A |
Pharmacia and Upjohn Company LLC | 0009-0106 | Taliglucerase alfa | 2012-05-01 | 2026-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (200U/5mL) |
| 29/01/2026 | Protalix BioTherapeutics |
Israel |
Protalix Ltd | 50210-248 | Taliglucerase alfa | 2012-05-01 | 2026-12-31 | BULK INGREDIENT | INJECTION, POWDER, FOR SOLUTION (150000U/150000U) |
